Yorkshire-based life sciences firm Aptamer Group has announced the launch of a new programme to develop targeted ...

Aptamer Group launched a targeted radiopharmaceutical development programme on Wednesday, expanding its pipeline in a ...

With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...

Researchers at Osaka Metropolitan University along with their international collaborators report that they have developed a nanofluidic device capable of capturing single proteins stochastically and ...

Nanomedicine. 2013;8(6):983-993. Fan and coworkers reported novel multicolor fluorescent Apt–AuNPs for homogeneous detection of small-molecule targets. [45] First, the multicolor dye-labeled aptamers ...

Single-stranded molecules of DNA called “aptamers” have been studied since 1990 for their ability to bind and inhibit molecular targets, a useful behavior for disease detection and drug delivery ...